Re: Association between endothelin receptor B nonsynonymous variants and melanoma risk [1]

Journal of the National Cancer Institute

Volumn 98, Issue 17, 2006, Pages 1252-1253

  Thirumaran, Ranjit K ^a   Thoelke, Adina ^a   Ugurel, Selma ^a   Hemminki, Kari ^a,b   Schadendorf, Dirk ^a   Kumar, Rajiv ^a,b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN B RECEPTOR;

ADOLESCENT; ADULT; AGED; CANCER RISK; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA EXTRACTION; DNA SEQUENCE; EMBRYO DEVELOPMENT; EXON; FEMALE; GENE FREQUENCY; GENE MUTATION; GENE OVEREXPRESSION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MELANOCYTE; MELANOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN VARIANT; SCHOOL CHILD; STATISTICAL ANALYSIS; STEM CELL;

ADENOSINE TRIPHOSPHATASES; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CATION TRANSPORT PROTEINS; CHILD; FEMALE; GENOTYPE; GERMANY; HUMANS; MALE; MELANOMA; MIDDLE AGED; MUTATION; ODDS RATIO; POLYMORPHISM, GENETIC; RECEPTOR, ENDOTHELIN B; RISK ASSESSMENT; RISK FACTORS; SKIN NEOPLASMS; VARIATION (GENETICS);

EID: 33748682304     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djj336     Document Type: Letter

References (6)

1. Hayward NK. Genetics of melanoma predisposition. Oncogene 2003;22:3053-62.
2. Soufir N, Meziani R, Lacapere JJ, Bertrand G, Fumeron F, Bourillon A, et al. Association between endothelin receptor B nonsynonymous variants and melanoma risk. J Natl Cancer Inst 2005;97:1297-301.
3. Lahav R. Endothelin receptor B is required for the expansion of melanocyte precursors and malignant melanoma. Int J Dev Biol 2005; 49:173-80.
4. Bittner M, Meltzer P, Chen Y, Jiang Y, Seftor E, Hendrix M, et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 2000;406:536-40.
5. Lahav R, Suva ML, Rimoldi D, Patterson PH, Stamenkovic I. Endothelin receptor B inhibition triggers apoptosis and enhances angiogenesis in melanomas. Cancer Res 2004;64:8945-53.
6. Auricchio A, Casari G, Staiano A, Ballabio A. Endothelin-B receptor mutations in patients with isolated Hirschsprung disease from a non-inbred population. Hum Mol Genet 1996; 5:351-4.